Optimization of pre-analytical heat treatment for inhibitor detection in haemophilia A.

International Journal of Laboratory Hematology
Paul BattySean Platton

Abstract

Factor VIII (FVIII) antibody formation is the greatest clinical and laboratory challenge within the haemophilia centre. The Nijmegen-Bethesda assay (NBA) is the gold standard for inhibitor quantification, but affected by pre-analytical variables including a patient's FVIII activity (FVIII:C). Pre-analytical heat treatment (PHT) provides a methodology for inhibitor testing when measurable FVIII:C is present. We evaluated the effect of different PHT conditions (time/temperature) on FVIII:C as well as on potency of inhibitory activity in samples containing FVIII:C (endogenous pooled plasma and exogenous recombinant FVIII (rFL-FVIII) concentrate) or FVIII inhibitor. PHT of endogenous FVIII at 37°C, 47°C and 52°C resulted in declining measurable FVIII:C at 120 minutes (69%, 57% and 13% of the original FVIII:C, respectively). Incubation at 56°C resulted in FVIII:C ≤ 1IU/dL after 60 minutes for endogenous FVIII and 120 minutes for rFL-FVIII. Incubation at 58°C resulted in FVIII:C < 1IU/dL at 15-30 minutes for endogenous FVIII and at 30-60 minutes for rFL-FVIII. No difference was seen for inhibitor detection following PHT (56°C or 58°C) by NBA or anti-FVIII IgG ELISA. PHT at 58°C for 30 minutes demonstrated consistent reduction in FVII...Continue Reading

References

Jan 31, 2008·Haemophilia : the Official Journal of the World Federation of Hemophilia·P M MannucciE Santagostino
Apr 17, 2009·The New England Journal of Medicine·Kevin R VielTom E Howard
Feb 20, 2010·Seminars in Thrombosis and Hemostasis·Bert VerbruggenBritta A P Laros-van Gorkom
Mar 23, 2012·Journal of Thrombosis and Haemostasis : JTH·C H MillerUNKNOWN Hemophilia Inhibitor Research Study Investigators
Mar 31, 2012·Haemophilia : the Official Journal of the World Federation of Hemophilia·M SahudJ Dlott
Nov 20, 2012·British Journal of Haematology·Peter W CollinsUNKNOWN UK Haemophilia Centre Doctors
Aug 9, 2013·Blood·Corien L EckhardtUNKNOWN INSIGHT Study Group
Nov 26, 2014·Haemophilia : the Official Journal of the World Federation of Hemophilia·P BattyD P Hart
Apr 17, 2015·Thrombosis and Haemostasis·Alice S van VelzenUNKNOWN INSIGHT study group
Oct 4, 2015·Thrombosis Research·Connie H Miller
Feb 21, 2018·Haemophilia : the Official Journal of the World Federation of Hemophilia·B Boylan, C H Miller

❮ Previous
Next ❯

Citations

Feb 13, 2019·Haemophilia : the Official Journal of the World Federation of Hemophilia·Kara A FyllingRajiv K Pruthi
Mar 3, 2021·Haemophilia : the Official Journal of the World Federation of Hemophilia·Paul BattyDaniel P Hart

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.